E-LIB Suche - Ergebnisse für: Jacqmin, Philippe

1

Efficacy and safety of emapalumab in macrophage activation ..:

De Benedetti, Fabrizio ; Grom, Alexei A ; Brogan, Paul A...
Annals of the Rheumatic Diseases. 82 (2023) 6 - p. 857-865 , 2023

Link: https://doi.org/10.1136/..

2

Mechanistic modeling projections of antibody persistence af..:

Dari, Anna ; Jacqmin, Philippe ; Iwaki, Yuki...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 10 - p. 1485-1498 , 2023

Link: https://doi.org/10.1002/..

3

Emapalumab in primary haemophagocytic lymphohistiocytosis a..:

Jacqmin, Philippe ; Laveille, Christian ; Snoeck, Eric...
British Journal of Clinical Pharmacology. 88 (2021) 5 - p. 2128-2139 , 2021

Link: https://doi.org/10.1111/..

4

Prediction of Survival Benefit of Filgrastim in Adult and P..:

Harrold, John ; Gisleskog, Per Olsson ; Perez‐Ruixo, Juan Jose...
Clinical and Translational Science. 13 (2020) 4 - p. 807-817 , 2020

Link: https://doi.org/10.1111/..

5

Clustering and Kernel Density Estimation for Assessment of ..:

Jacqmin, Hugues ; Chatelain, Bernard ; Louveaux, Quentin...
Diagnostics. 10 (2020) 5 - p. 317 , 2020

Link: https://doi.org/10.3390/..

6

Quantification of Radiation Injury on Neutropenia and the L..:

Harrold, John ; Gisleskog, Per Olsson ; Delor, Isabelle...
Pharmaceutical Research. 37 (2020) 6 - p. , 2020

Link: https://doi.org/10.1007/..

7

Mathematical Disease Progression Modeling in Type 2/3 Spina..:

Jacqmin, Philippe ; Gieschke, Ronald ; Delor, Isabelle...
Muscle & Nerve. 58 (2018) 4 - p. 528-535 , 2018

Link: https://doi.org/10.1002/..

8

Pharmacokinetic–pharmacodynamic modelling of neutrophil res..:

Melhem, Murad ; Delor, Isabelle ; Pérez‐Ruixo, Juan Jose...
British Journal of Clinical Pharmacology. 84 (2018) 5 - p. 911-925 , 2018

Link: https://doi.org/10.1111/..

9

Population pharmacokinetic evaluation of ADV6209, an innova..:

Marçon, Frédéric ; Guittet, Catherine ; Manso, Maria A....
European Journal of Pharmaceutical Sciences. 114 (2018) - p. 46-54 , 2018

Link: https://doi.org/10.1016/..

10

Using early biomarker data to predict long-term bone minera..:

Zheng, Jenny ; van Schaick, Erno ; Wu, Liviawati Sutjandra..
Journal of Pharmacokinetics and Pharmacodynamics. 42 (2015) 4 - p. 333-347 , 2015

Link: https://doi.org/10.1007/..

11

A semi-mechanistic model of bone mineral density and bone t..:

van Schaick, Erno ; Zheng, Jenny ; Ruixo, Juan Jose Perez..
Journal of Pharmacokinetics and Pharmacodynamics. 42 (2015) 4 - p. 315-332 , 2015

Link: https://doi.org/10.1007/..

12

Population pharmacokinetics of four β-lactams in critically..:

Delattre, Isabelle K. ; Musuamba, Flora T. ; Jacqmin, Philippe...
Clinical Biochemistry. 45 (2012) 10-11 - p. 780-786 , 2012

Link: https://doi.org/10.1016/..

13

Basic PK/PD principles of drug effects in circular/prolifer..:

Jacqmin, Philippe ; McFadyen, Lynn ; Wade, Janet R.
Journal of Pharmacokinetics and Pharmacodynamics. 37 (2010) 2 - p. 157-177 , 2010

Link: https://doi.org/10.1007/..

14

The use of the SAEM algorithm in MONOLIX software for estim..:

Chan, Phylinda L. S. ; Jacqmin, Philippe ; Lavielle, Marc..
Journal of Pharmacokinetics and Pharmacodynamics. 38 (2010) 1 - p. 41-61 , 2010

Link: https://doi.org/10.1007/..

15

An example of optimal phase II design for exposure response..:

Maloney, Alan ; Schaddelee, Marloes ; Freijer, Jan...
Journal of Pharmacokinetics and Pharmacodynamics. 37 (2010) 5 - p. 475-491 , 2010

Link: https://doi.org/10.1007/..